GODREJ AGROVET: Big miss; Crop Protection drags 2Q; But animal feed segment – the star performer
(GOAGRO IN, Mkt Cap USD1.4b, CMP INR501, TP INR584, 17% Upside, Buy)
Miss on EBITDA while PAT above est.: revenue grew 17% YoY to INR18.5b (v/s est. INR18.9b), mainly led by the animal feed segment (+32% YoY to INR9.4b). EBITDA margin contracted 240bp YoY to 6.5% (v/s est. 8.3%), mainly due to lower margin in crop protection and palm oil. EBITDA declined 15% YoY to INR1,197m (v/s est. INR1,561m). Adj. PAT was up 10% YoY to INR1,040m due to deferred tax benefit (v/s est. INR958m).
Godrej Agrovet Ltd is an India-based agribusiness company. The Company engages in animal feed, oil palm plantations, agrochemicals, poultry. It focuses to improving the productivity of Indian farmers by products and services that increase crop and livestock yields. The Company offers Dripzyme, a technique of drip irrigation. Dripzyme helps in growth of additional branches, flower and fruit buds. The Company helps in creating a root system giving plants greater access to nutrients and water in the soil thereby enhancing the nutritional value of the yield. The Company operates crop protection, godrej tyson foods, aci godrej agrovet, creamline dairy products and astec lifesciences.
Motilal Oswal Financial Services Ltd. is a reputed name in Financial Services and Online Trading with group companies providing services such as Private Wealth Management, Retail Broking and Distribution, Institutional Broking, Asset Management, Investment Banking, Private Equity, Commodity Broking, Currency Broking, Principal Strategies & Home Finance.
Motilal Oswal Securities is a group company of Motilal Oswal Financial Service Limited which started as a stock trading company and has blossomed into well diversified firm offering a range of financial products and services. Motilal Oswal has built a reputation as the source for best stock trading company and this has taken a wealth of experience, knowledge and expertise, constantly working in tandem, over the years.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.